Cargando…

A concealed history behind the disaster: Extremely rare presentations of metformin toxicity in a patient with body dysmorphic disorder

Metformin is a widely used anti-hyperglycemic agent with weight loss effect properties but besides its various utilities, despite being very rare, it has its characteristic toxicity and adverse effects when used in large doses and for the long-term or in patients with renal impairment. We presented...

Descripción completa

Detalles Bibliográficos
Autores principales: Hajsadeghi, Shokoufeh, Gholizadeh Mesgarha, Milad, Pour Mohammad, Arash, Saberi Shahrbabaki, Ali, Talebi, Aisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764204/
https://www.ncbi.nlm.nih.gov/pubmed/36561946
http://dx.doi.org/10.1016/j.toxrep.2022.04.004
_version_ 1784853226352279552
author Hajsadeghi, Shokoufeh
Gholizadeh Mesgarha, Milad
Pour Mohammad, Arash
Saberi Shahrbabaki, Ali
Talebi, Aisa
author_facet Hajsadeghi, Shokoufeh
Gholizadeh Mesgarha, Milad
Pour Mohammad, Arash
Saberi Shahrbabaki, Ali
Talebi, Aisa
author_sort Hajsadeghi, Shokoufeh
collection PubMed
description Metformin is a widely used anti-hyperglycemic agent with weight loss effect properties but besides its various utilities, despite being very rare, it has its characteristic toxicity and adverse effects when used in large doses and for the long-term or in patients with renal impairment. We presented here a case of a 36-year-old woman who developed several presentations with diverse features during three years comprising neuropathic symptoms, severe lactic acidosis, three episodes of cardiogenic shock, acute kidney injury, megaloblastic anemia, pancytopenia, and hyponatremia and did not receive a definite diagnosis after each presentation until when she inadvertently disclosed her abuse of extremely unusual doses of metformin during these three years with aim of weight reduction obsessively without knowing that her symptoms could pertain to metformin overdose. She was eventually diagnosed with a body dysmorphic disorder which led to unreasonable abuse of metformin pills that consequently caused its toxicity. Thereafter, with cease of metformin use and psychiatric treatment, her symptoms did not recur and she was doing well after one year of her last admission. Based on the review of the literature, this is the first case of metformin toxicity in a patient with body dysmorphic disorder who was affected with extremely rare features of this intoxication, nevertheless, every manifestation of the patient was discussed exhaustively according to the current and available medical literature.
format Online
Article
Text
id pubmed-9764204
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-97642042022-12-21 A concealed history behind the disaster: Extremely rare presentations of metformin toxicity in a patient with body dysmorphic disorder Hajsadeghi, Shokoufeh Gholizadeh Mesgarha, Milad Pour Mohammad, Arash Saberi Shahrbabaki, Ali Talebi, Aisa Toxicol Rep Regular Article Metformin is a widely used anti-hyperglycemic agent with weight loss effect properties but besides its various utilities, despite being very rare, it has its characteristic toxicity and adverse effects when used in large doses and for the long-term or in patients with renal impairment. We presented here a case of a 36-year-old woman who developed several presentations with diverse features during three years comprising neuropathic symptoms, severe lactic acidosis, three episodes of cardiogenic shock, acute kidney injury, megaloblastic anemia, pancytopenia, and hyponatremia and did not receive a definite diagnosis after each presentation until when she inadvertently disclosed her abuse of extremely unusual doses of metformin during these three years with aim of weight reduction obsessively without knowing that her symptoms could pertain to metformin overdose. She was eventually diagnosed with a body dysmorphic disorder which led to unreasonable abuse of metformin pills that consequently caused its toxicity. Thereafter, with cease of metformin use and psychiatric treatment, her symptoms did not recur and she was doing well after one year of her last admission. Based on the review of the literature, this is the first case of metformin toxicity in a patient with body dysmorphic disorder who was affected with extremely rare features of this intoxication, nevertheless, every manifestation of the patient was discussed exhaustively according to the current and available medical literature. Elsevier 2022-04-12 /pmc/articles/PMC9764204/ /pubmed/36561946 http://dx.doi.org/10.1016/j.toxrep.2022.04.004 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Regular Article
Hajsadeghi, Shokoufeh
Gholizadeh Mesgarha, Milad
Pour Mohammad, Arash
Saberi Shahrbabaki, Ali
Talebi, Aisa
A concealed history behind the disaster: Extremely rare presentations of metformin toxicity in a patient with body dysmorphic disorder
title A concealed history behind the disaster: Extremely rare presentations of metformin toxicity in a patient with body dysmorphic disorder
title_full A concealed history behind the disaster: Extremely rare presentations of metformin toxicity in a patient with body dysmorphic disorder
title_fullStr A concealed history behind the disaster: Extremely rare presentations of metformin toxicity in a patient with body dysmorphic disorder
title_full_unstemmed A concealed history behind the disaster: Extremely rare presentations of metformin toxicity in a patient with body dysmorphic disorder
title_short A concealed history behind the disaster: Extremely rare presentations of metformin toxicity in a patient with body dysmorphic disorder
title_sort concealed history behind the disaster: extremely rare presentations of metformin toxicity in a patient with body dysmorphic disorder
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764204/
https://www.ncbi.nlm.nih.gov/pubmed/36561946
http://dx.doi.org/10.1016/j.toxrep.2022.04.004
work_keys_str_mv AT hajsadeghishokoufeh aconcealedhistorybehindthedisasterextremelyrarepresentationsofmetformintoxicityinapatientwithbodydysmorphicdisorder
AT gholizadehmesgarhamilad aconcealedhistorybehindthedisasterextremelyrarepresentationsofmetformintoxicityinapatientwithbodydysmorphicdisorder
AT pourmohammadarash aconcealedhistorybehindthedisasterextremelyrarepresentationsofmetformintoxicityinapatientwithbodydysmorphicdisorder
AT saberishahrbabakiali aconcealedhistorybehindthedisasterextremelyrarepresentationsofmetformintoxicityinapatientwithbodydysmorphicdisorder
AT talebiaisa aconcealedhistorybehindthedisasterextremelyrarepresentationsofmetformintoxicityinapatientwithbodydysmorphicdisorder
AT hajsadeghishokoufeh concealedhistorybehindthedisasterextremelyrarepresentationsofmetformintoxicityinapatientwithbodydysmorphicdisorder
AT gholizadehmesgarhamilad concealedhistorybehindthedisasterextremelyrarepresentationsofmetformintoxicityinapatientwithbodydysmorphicdisorder
AT pourmohammadarash concealedhistorybehindthedisasterextremelyrarepresentationsofmetformintoxicityinapatientwithbodydysmorphicdisorder
AT saberishahrbabakiali concealedhistorybehindthedisasterextremelyrarepresentationsofmetformintoxicityinapatientwithbodydysmorphicdisorder
AT talebiaisa concealedhistorybehindthedisasterextremelyrarepresentationsofmetformintoxicityinapatientwithbodydysmorphicdisorder